Antwerp (Belgium)\/ France \u2014 Biolam and Gimv today announce an important step on Biolam\u2019s growth path. Follo\u00adwing the rapid and successful deve\u00adlo\u00adp\u00adment of the group, which combi\u00adnes orga\u00adnic and exter\u00adnal growth, Gimv is selling its shares in Biolam to the foun\u00adding team, which is supported by private inves\u00adtors. The foun\u00adders, manage\u00adment and their new part\u00adners will conti\u00adnue to focus on quality of service and care and expan\u00adsion in France.<\/p>\n
In 2019, Gimv acqui\u00adred a stake with Daniel Attias in Biolam (www.groupebiolam.fr), an emer\u00adging group of clini\u00adcal test\u00ading labo\u00adra\u00adto\u00adries in the city of Amiens. The origi\u00adnal plan, deve\u00adlo\u00adped with Daniel Attias, aimed to create a leading player in the Hauts-de-France region in terms of size, clini\u00adcal perfor\u00admance and level of service.<\/p>\n
From the begin\u00adning, Biolam has grown very quickly thanks to a combi\u00adna\u00adtion of estab\u00adli\u00adshing labo\u00adra\u00adto\u00adries in under\u00adser\u00adved loca\u00adti\u00adons, which is an important prere\u00adqui\u00adsite for acces\u00adsi\u00adble quality care, and stra\u00adte\u00adgic acqui\u00adsi\u00adti\u00adons. In paral\u00adlel, the Group conti\u00adnuously inves\u00adted in staff, care orga\u00adniza\u00adtion, diagno\u00adstic equip\u00adment and IT back\u00adbone to support its ambi\u00adtious medi\u00adcal project. These efforts have enab\u00adled Biolam to become a leading labo\u00adra\u00adtory group in the Hauts-de-France and Normandy region, with a solid foun\u00adda\u00adtion for contin\u00adued success.<\/p>\n
The company curr\u00adently opera\u00adtes a network of more than 30 labo\u00adra\u00adto\u00adries with 4 tech\u00adni\u00adcal plat\u00adforms and has an exten\u00adsive pipe\u00adline of active acqui\u00adsi\u00adtion targets. Since Gimv\u2019s invest\u00adment in 2019, Biolam has signed 7 addi\u00adtio\u00adnal acqui\u00adsi\u00adti\u00adons and built a leading and high-quality diagno\u00adstics organization.<\/p>\n
The tran\u00adsac\u00adtion announ\u00adced today will streng\u00adthen the company\u2019s relent\u00adless focus on quality service and care, as well as expan\u00adsion in its regi\u00adons. The manage\u00adment team, toge\u00adther with its new part\u00adners, will conti\u00adnue to invest in its orga\u00adniza\u00adtion while expan\u00adding its labo\u00adra\u00adtory network to create an even better diagno\u00adstics company for all stakeholders.<\/p>\n
The tran\u00adsac\u00adtion has no mate\u00adrial impact on the net asset value of Gimv as of Septem\u00adber 30, 2022. Further finan\u00adcial details will not be disclosed.<\/p>\n
Gautier Lefeb\u00advre, Part\u00adner at Gimv, and Kevin Klein, Prin\u00adci\u00adpal at Gimv.<\/strong>, state, \u201cWe are very proud to have part\u00adne\u00adred with Biolam and Daniel Attias on the company\u2019s growth stra\u00adtegy, which has always put the quality of diagno\u00adstics and level of service to physi\u00adci\u00adans first, espe\u00adci\u00adally during the pande\u00admic. From the begin\u00adning, we were perfectly aligned with the manage\u00adment team, resul\u00adting in an opti\u00admal ability to build the busi\u00adness and seize growth oppor\u00adtu\u00adni\u00adties. We would like to thank the manage\u00adment of Biolam for their successful and excel\u00adlent coope\u00adra\u00adtion and wish them \u2014 toge\u00adther with their new part\u00adners \u2014 all the best for their further growth.\u201d<\/p>\n Daniel Attias, Chair\u00adman of the Biolam Group<\/strong>, says, \u201cWe have excee\u00added the goals we origi\u00adnally set with the Gimv team, which is a sign of very effec\u00adtive colla\u00adbo\u00adra\u00adtion. We are grateful for the successful part\u00adner\u00adship with Gimv that has enab\u00adled Biolam\u2019s evolu\u00adtion into an estab\u00adlished and leading labo\u00adra\u00adtory group with a solid foun\u00adda\u00adtion for the next phase of growth, and we look forward to conti\u00adnuing to grow with our new partners.\u201d<\/p>\n Trans\u00adla\u00adted with www.DeepL.com\/Translator (free version)<\/p>\n","protected":false},"excerpt":{"rendered":" Antwerp (Belgium)\/ France \u2014 Biolam and Gimv today announce an important step on Biolam\u2019s growth path. Follo\u00adwing the rapid and successful deve\u00adlo\u00adp\u00adment of the group, which combi\u00adnes orga\u00adnic and exter\u00adnal growth, Gimv is selling its shares in Biolam to the foun\u00adding team, which is supported by private inves\u00adtors. The foun\u00adders, manage\u00adment and their new partners [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":47314,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1367,1369],"tags":[],"class_list":["post-47316","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-investors"],"yoast_head":"\n